I am wondering why they are both price sensitive announcements and needed a trading halt and at the same time they will have no material impact on the financial performance of Rap (in the short term at least). Seems to be contradictory.
Ann: Alodokter to launch ResAppDx in Indonesia, page-75
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #